Chinese venture capital firm Qiming Venture Partners is planning to raise US$250 million for its second healthcare-focused fund to finance early-stage companies in the United States, according to a regulatory document filed on January 30.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription?